Wanbangde Pharmaceutical Holding Group Co Ltd
SZSE:002082
Income Statement
Earnings Waterfall
Wanbangde Pharmaceutical Holding Group Co Ltd
Revenue
|
1.6B
CNY
|
Cost of Revenue
|
-885.7m
CNY
|
Gross Profit
|
735m
CNY
|
Operating Expenses
|
-746.4m
CNY
|
Operating Income
|
-11.3m
CNY
|
Other Expenses
|
-50.1m
CNY
|
Net Income
|
-61.4m
CNY
|
Income Statement
Wanbangde Pharmaceutical Holding Group Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
11 485
N/A
|
11 786
+3%
|
11 434
-3%
|
11 498
+1%
|
11 747
+2%
|
11 452
-3%
|
11 003
-4%
|
10 833
-2%
|
11 227
+4%
|
11 572
+3%
|
11 349
-2%
|
10 485
-8%
|
9 262
-12%
|
9 183
-1%
|
10 114
+10%
|
11 360
+12%
|
13 112
+15%
|
14 635
+12%
|
14 637
+0%
|
15 203
+4%
|
14 804
-3%
|
14 335
-3%
|
15 036
+5%
|
16 116
+7%
|
16 732
+4%
|
16 691
0%
|
15 839
-5%
|
15 170
-4%
|
15 432
+2%
|
13 702
-11%
|
11 723
-14%
|
7 935
-32%
|
3 787
-52%
|
1 931
-49%
|
1 681
-13%
|
1 733
+3%
|
1 818
+5%
|
1 786
-2%
|
1 839
+3%
|
1 794
-2%
|
1 621
-10%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(11 234)
|
(11 514)
|
(11 173)
|
(11 228)
|
(11 467)
|
(11 180)
|
(10 752)
|
(10 588)
|
(10 998)
|
(11 389)
|
(11 169)
|
(10 318)
|
(9 107)
|
(9 009)
|
(9 954)
|
(11 211)
|
(12 943)
|
(14 409)
|
(14 380)
|
(14 863)
|
(14 395)
|
(13 815)
|
(14 371)
|
(15 248)
|
(15 704)
|
(15 264)
|
(14 427)
|
(13 765)
|
(13 967)
|
(12 361)
|
(10 437)
|
(6 748)
|
(2 739)
|
(997)
|
(774)
|
(895)
|
(896)
|
(852)
|
(922)
|
(910)
|
(886)
|
|
Gross Profit |
251
N/A
|
273
+9%
|
262
-4%
|
270
+3%
|
280
+4%
|
272
-3%
|
252
-7%
|
245
-3%
|
229
-7%
|
183
-20%
|
180
-1%
|
167
-7%
|
155
-8%
|
175
+13%
|
160
-9%
|
149
-7%
|
169
+14%
|
226
+33%
|
256
+13%
|
340
+33%
|
409
+20%
|
520
+27%
|
665
+28%
|
868
+31%
|
1 028
+18%
|
1 427
+39%
|
1 412
-1%
|
1 405
0%
|
1 465
+4%
|
1 341
-8%
|
1 287
-4%
|
1 187
-8%
|
1 048
-12%
|
933
-11%
|
907
-3%
|
838
-8%
|
922
+10%
|
935
+1%
|
917
-2%
|
884
-4%
|
735
-17%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(110)
|
(125)
|
(107)
|
(126)
|
(137)
|
(140)
|
(132)
|
(123)
|
(110)
|
(105)
|
(104)
|
(103)
|
(96)
|
(100)
|
(91)
|
(87)
|
(102)
|
(146)
|
(164)
|
(226)
|
(280)
|
(356)
|
(437)
|
(564)
|
(665)
|
(848)
|
(837)
|
(855)
|
(1 010)
|
(881)
|
(946)
|
(881)
|
(665)
|
(648)
|
(728)
|
(684)
|
(749)
|
(691)
|
(766)
|
(761)
|
(746)
|
|
Selling, General & Administrative |
(110)
|
(116)
|
(120)
|
(133)
|
(142)
|
(132)
|
(131)
|
(120)
|
(108)
|
(96)
|
(101)
|
(99)
|
(95)
|
(93)
|
(88)
|
(86)
|
(98)
|
(122)
|
(173)
|
(193)
|
(215)
|
(241)
|
(326)
|
(432)
|
(525)
|
(689)
|
(701)
|
(739)
|
(797)
|
(690)
|
(697)
|
(666)
|
(574)
|
(611)
|
(609)
|
(563)
|
(656)
|
(593)
|
(623)
|
(624)
|
(584)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(22)
|
0
|
0
|
(34)
|
(96)
|
(89)
|
(137)
|
(148)
|
(155)
|
(160)
|
(157)
|
(170)
|
(172)
|
(182)
|
(149)
|
(108)
|
(63)
|
(69)
|
(72)
|
(70)
|
(45)
|
(59)
|
(58)
|
(54)
|
|
Depreciation & Amortization |
0
|
(9)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(37)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(64)
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
(1)
|
13
|
7
|
5
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(1)
|
0
|
(3)
|
(1)
|
(4)
|
6
|
10
|
(33)
|
(31)
|
6
|
(21)
|
4
|
9
|
32
|
24
|
41
|
(43)
|
22
|
(67)
|
(66)
|
18
|
74
|
(49)
|
(49)
|
(23)
|
11
|
(83)
|
(79)
|
(108)
|
|
Operating Income |
140
N/A
|
147
+5%
|
155
+6%
|
144
-7%
|
143
-1%
|
131
-8%
|
120
-9%
|
122
+2%
|
118
-3%
|
78
-34%
|
77
-2%
|
64
-16%
|
58
-10%
|
74
+28%
|
68
-8%
|
61
-10%
|
68
+10%
|
81
+20%
|
93
+14%
|
114
+23%
|
129
+13%
|
164
+27%
|
228
+39%
|
304
+33%
|
363
+20%
|
579
+59%
|
575
-1%
|
550
-4%
|
455
-17%
|
459
+1%
|
341
-26%
|
306
-10%
|
383
+25%
|
285
-26%
|
180
-37%
|
154
-14%
|
173
+13%
|
244
+41%
|
151
-38%
|
122
-19%
|
(11)
N/A
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(13)
|
(8)
|
(5)
|
(2)
|
(0)
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
4
|
7
|
7
|
7
|
11
|
5
|
1
|
(3)
|
(16)
|
(22)
|
(36)
|
(43)
|
(52)
|
(53)
|
(55)
|
(57)
|
(43)
|
(36)
|
139
|
175
|
166
|
(35)
|
27
|
(5)
|
3
|
(24)
|
(26)
|
(26)
|
(36)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(2)
|
(2)
|
0
|
31
|
31
|
31
|
31
|
4
|
0
|
4
|
4
|
(11)
|
0
|
0
|
0
|
(77)
|
(0)
|
(0)
|
(0)
|
125
|
0
|
(1)
|
(1)
|
(91)
|
0
|
(1)
|
(2)
|
|
Gain/Loss on Disposition of Assets |
0
|
(1)
|
0
|
0
|
(0)
|
(1)
|
0
|
0
|
0
|
(2)
|
(3)
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(1)
|
4
|
4
|
3
|
4
|
4
|
3
|
1
|
3
|
4
|
6
|
8
|
7
|
6
|
8
|
7
|
8
|
1
|
(1)
|
(3)
|
(4)
|
(3)
|
(4)
|
(4)
|
(5)
|
(3)
|
(4)
|
(6)
|
2
|
1
|
2
|
8
|
(3)
|
(14)
|
(10)
|
(15)
|
(15)
|
(29)
|
(33)
|
(31)
|
(28)
|
|
Pre-Tax Income |
127
N/A
|
142
+12%
|
154
+8%
|
145
-6%
|
146
+0%
|
136
-7%
|
123
-9%
|
125
+1%
|
124
-1%
|
83
-33%
|
82
-1%
|
72
-13%
|
64
-11%
|
81
+27%
|
80
-1%
|
73
-9%
|
87
+19%
|
118
+36%
|
122
+4%
|
138
+13%
|
139
+1%
|
143
+3%
|
188
+32%
|
261
+38%
|
309
+19%
|
512
+65%
|
516
+1%
|
487
-6%
|
414
-15%
|
348
-16%
|
481
+38%
|
489
+2%
|
547
+12%
|
361
-34%
|
197
-46%
|
132
-33%
|
160
+21%
|
100
-37%
|
92
-8%
|
64
-30%
|
(77)
N/A
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(18)
|
(24)
|
(26)
|
(24)
|
(24)
|
(22)
|
(20)
|
(18)
|
(17)
|
(15)
|
(15)
|
(14)
|
(11)
|
(8)
|
(9)
|
(9)
|
(10)
|
(18)
|
(20)
|
(23)
|
(28)
|
(18)
|
(27)
|
(40)
|
(47)
|
(95)
|
(96)
|
(85)
|
(83)
|
(56)
|
(211)
|
(212)
|
(224)
|
(200)
|
(41)
|
(31)
|
(15)
|
(26)
|
(16)
|
(12)
|
3
|
|
Income from Continuing Operations |
109
|
117
|
128
|
121
|
122
|
113
|
104
|
107
|
107
|
68
|
67
|
58
|
53
|
73
|
71
|
64
|
76
|
100
|
103
|
115
|
112
|
125
|
162
|
221
|
262
|
417
|
420
|
401
|
331
|
292
|
270
|
278
|
323
|
161
|
156
|
102
|
145
|
74
|
76
|
52
|
(74)
|
|
Income to Minority Interest |
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(3)
|
(12)
|
(23)
|
(41)
|
(42)
|
(40)
|
(45)
|
(123)
|
(122)
|
(117)
|
(101)
|
(7)
|
(5)
|
(1)
|
(7)
|
5
|
8
|
10
|
18
|
20
|
20
|
16
|
13
|
|
Net Income (Common) |
104
N/A
|
112
+7%
|
122
+9%
|
115
-6%
|
115
+1%
|
108
-6%
|
97
-10%
|
102
+4%
|
101
0%
|
63
-38%
|
62
-1%
|
53
-14%
|
49
-8%
|
70
+43%
|
68
-3%
|
61
-10%
|
74
+20%
|
98
+33%
|
100
+2%
|
103
+3%
|
89
-14%
|
84
-6%
|
120
+43%
|
181
+51%
|
218
+20%
|
295
+36%
|
298
+1%
|
284
-5%
|
230
-19%
|
285
+24%
|
265
-7%
|
277
+4%
|
316
+14%
|
167
-47%
|
164
-2%
|
112
-31%
|
163
+45%
|
94
-42%
|
96
+3%
|
67
-30%
|
(61)
N/A
|
|
EPS (Diluted) |
0.43
N/A
|
0.47
+9%
|
0.51
+9%
|
0.48
-6%
|
0.49
+2%
|
0.45
-8%
|
0.41
-9%
|
0.43
+5%
|
0.42
-2%
|
0.26
-38%
|
0.26
N/A
|
0.22
-15%
|
0.21
-5%
|
0.29
+38%
|
0.28
-3%
|
0.25
-11%
|
0.3
+20%
|
0.41
+37%
|
0.42
+2%
|
0.44
+5%
|
0.38
-14%
|
0.35
-8%
|
0.18
-49%
|
0.29
+61%
|
0.35
+21%
|
0.59
+69%
|
0.48
-19%
|
0.45
-6%
|
0.37
-18%
|
0.47
+27%
|
0.42
-11%
|
0.47
+12%
|
0.53
+13%
|
0.27
-49%
|
0.26
-4%
|
0.18
-31%
|
0.27
+50%
|
0.15
-44%
|
0.17
+13%
|
0.13
-24%
|
-0.09
N/A
|